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Additional ﬁ le 2.  Expression of miR-21 and TM1 in different tissue compo-
nents of the breast 
patient 
number
normal breast FEA DCIS patient 
number
IDC
miR-21 TM1 miR-21 TM1 miR-21 TM1 miR-21 TM1
1 - + - ++ ± + 16 ± -
2 + ++ + ++ + + 18 + ++
3 - ++ + ++ na na 19 + -
4 - ++ + + + - 20 + -
5 - ++ + ++ + + 21 + +
6 - ++ - +++ na na 22 + -
7 - ++ - ++ + + 23 - -
8 + ++ - ++ + ++ 24 - +
9 - na - +++ - +++ 25 + -
10 - ++ ± ++ + - 26 + -
11 - ++ + ++ + + 27 + -
12 - + - ++ - ++ 28 + -
13 - + - +++ na na 30 + +
14 - ++ - + - ++ 31 + -
15 - + + ++ + + 32 + -
35 + -
36 ± -
Note: the light blue and dark blue boxes indicate the tissue components with an inversed staining pattern for miR-21 and TM1 
Additional ﬁ le 1.  Expression of miR-21 and PTEN in different tissue com-
ponents of the breast 
patient 
number
normal breast FEA DCIS patient 
number
IDC
miR-21 PTEN miR-21 PTEN miR-21 PTEN miR-21 PTEN
1 - +++ - + ± ++ 16 ± ++
2 + +++ + +++ + +++ 18 + +++
3 - +++ + ++ na na 19 + ++
4 - +++ + ++ + +++ 20 + ++
5 - +++ + ++ + +++ 21 + +++
6 - +++ - + na na 22 + ++
7 - +++ - + + +++ 23 - +++
8 + +++ - +++ + +++ 24 - +++
9 - +++ - ++ - ++ 25 + ++
10 - +++ ± +++ + +++ 26 + ++
11 - +++ + +++ + +++ 27 + +++
12 - +++ - +++ - +++ 28 + +++
13 - +++ - +++ na na 30 + ++
14 - +++ - ++ - +++ 31 + ++
15 - +++ + +++ + ++ 32 + +++
35 + +++
36 ± +++
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